Akebia Therapeutics, Inc. lobbies on its own behalf. For Q3 2026 it reported $260K across 1 client report and lists 1 lobbyist across its filings. Issues include Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | $260K | Health Issues, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.10M | 1 |
| 2025 | $1.30M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.